FindTrial
Sign In

In our study we will be including patients with blunt thoracic injury of any kind. We will be giving acapella twice a day for removal of excess secretion to see the effect on pain on cough, SpO2 and vitals.

Feasibility of using acapella in stable post traumatic thoracic injury patients for management of excess secretion. A single arm pilot study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099854
Enrollment
15
Registered
2025-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified

Interventions

Intervention1: device acapella: Acapella will be used for clearing mucus secretion out through expectoration Control Intervention1: not applicable: not applicable

Sponsors

MGM Institute of Physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having blunt thoracic injury 2.Both males and females of 18 years of age

Exclusion criteria

Exclusion criteria: 1.Patients with unstable vitals 2.Patients on ventilatory support 3.Patient who are unconscious or comatose 4.Patients with higher spinal cord injuries

Design outcomes

Primary

MeasureTime frame
Pain on NPRSTimepoint: on Assessment—

Secondary

MeasureTime frame
Brethlessness, cough, sputum scale Timepoint: Pre and post intervention till discharge—

Countries

India

Contacts

Public ContactDr Vaibhav Kapre PT

MGM Institute of Physiotherapy

vaibhavkapre@mgmiop.edu.in9425346903

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026